|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.845 SEK | -0.27% |
|
-10.00% | -2.89% |
| 07-20 | Enzymatica CFO Holger Lembrér buys shares for 110,000 kronor | FW |
| 07-16 | Enzymatica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 448M 393M 366M 337M 631M 42.79B 642M 4.34B 1.7B 21.22B 1.68B 1.64B 73.31B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 416M 365M 340M 312M 586M 39.72B 596M 4.03B 1.58B 19.7B 1.56B 1.53B 68.05B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.27% | ||
| 1 week | -10.00% | ||
| Current month | -23.12% | ||
| 1 month | -26.20% | ||
| 3 months | -30.11% | ||
| 6 months | -2.64% | ||
| Current year | -2.89% |
| 1 week | 1.74 |  | 1.96 |
| 1 month | 1.61 | | 2.6 |
| Current year | 1.6 | | 3.4 |
| 1 year | 1.6 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 13.4 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 2026-01-31 |
Ulf Thomas Blom
COO | Chief Operating Officer | 61 | 2010-12-31 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 2026-04-12 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 2016-02-14 | |
Bengt Baron
CHM | Chairman | 64 | 2016-12-18 |
| Director/Board Member | 71 | 2016-12-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/17/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 4/1/26 | Sell | Responsable ventes & marketing | 40,000 | 0.0165% | ||
| 12/30/25 | Buy | Chairman | 20,000 | 0.0082% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | -10.00% | -31.92% | -37.14% | 46.19M | |
| +1.93% | +3.85% | +51.05% | +166.24% | 1,089B | |
| +0.29% | +6.43% | +60.47% | +52.87% | 643B | |
| +2.45% | +2.77% | +39.61% | +74.48% | 465B | |
| +2.17% | +10.22% | +41.17% | +36.56% | 359B | |
| +1.46% | +3.87% | +39.70% | +44.49% | 303B | |
| +0.40% | +3.59% | +19.93% | +17.02% | 267B | |
| +2.73% | +3.50% | -25.66% | -36.53% | 226B | |
| +4.48% | +7.33% | +30.47% | +66.31% | 212B | |
| +2.91% | +3.10% | +18.84% | +74.76% | 167B | |
| Average | +1.94% | +3.57% | +24.37% | +45.91% | 373.12B | |
| Weighted average by Cap. | +1.97% | +5.14% | +39.89% | +80.14% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 40M 37.25M 34.26M 64.22M 4.35B 65.32M 442M 173M 2.16B 171M 167M 7.46B | 53.9M 47.31M 44.05M 40.52M 75.95M 5.15B 77.25M 523M 205M 2.55B 202M 198M 8.82B |
| Net income | -53.18M -46.67M -43.46M -39.97M -74.93M -5.08B -76.22M -516M -202M -2.52B -200M -195M -8.71B | -51.89M -45.54M -42.41M -39M -73.12M -4.96B -74.37M -503M -197M -2.46B -195M -191M -8.49B |
| Net Debt | -73.01M -64.07M -59.67M -54.88M -103M -6.98B -105M -708M -277M -3.46B -274M -268M -11.95B | -32.11M -28.18M -26.24M -24.14M -45.25M -3.07B -46.02M -311M -122M -1.52B -121M -118M -5.26B |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-28 | SEK 1.845 | -0.27% | 42,595 |
| 26-07-27 | SEK 1.850 | -1.60% | 92,589 |
| 26-07-24 | SEK 1.880 | +0.80% | 104,975 |
| 26-07-23 | SEK 1.865 | +0.27% | 162,793 |
| 26-07-22 | SEK 1.860 | -9.27% | 392,131 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
